tirzepatide for sleep apnea fda approval approves weight-loss drug Zepbound to treat Obstructive sleep apnea with obesity:

87% have seen life-changing results* 93% agree Ro is easier to incorporate into their lives* 97% report silenced or quieter food noise since starting* Average weight loss in 1 year is 11-20% (vs ~2-3% with diet and exercise alone)

Spain: Drug agency warns of risk of sudden blindness from Ozempic It pointed out that patients who take semaglutide, an antidiabetic drug commonly known as Ozempic, are more likely to develop the condition

Symptoms include swelling, pain, tenderness, and redness, often in the calf

With a proactive, realistic plan, patients can protect their appearance while enjoying the metabolic and cardiovascular benefits of GLP-1s

The Phase 3 results are promising, but most of the programme is still running, and the long-term cardiovascular outcomes data wont be available until 2028 at the earliest

LH and FSH trigger the release of sex hormones (primarily estradiol in women and testosterone in men) The loop comes full circle with the sex hormones regulating the release of leptin, adiponectin, and other hormones in the brain responsible for metabolism and fat burning